20
Uquifa Mexico Sa De Cv, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ALBENDAZOLE, with a corresponding US DMF Number 25914.
Remarkably, this DMF maintains an Active status since its submission on March 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2014, and payment made on August 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II